Trials / Completed
CompletedNCT00161759
Safety and Efficacy Study of Fibrin Sealant (FS 4IU) for Skin Graft Fixation and Wound Healing in Subjects With Burn Wounds
A Study to Assess the Safety and Efficacy of Fibrin Sealant (FS 4IU) for Wound Healing in Subjects With Burn Wounds Requiring Skin Grafting Procedures
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- Baxter Healthcare Corporation · Industry
- Sex
- All
- Age
- 6 Years – 65 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to assess if Fibrin Sealant 4IU is as safe and efficacious as staples (the current standard of care) to achieve fixation of skin grafts and wound healing in subjects with burn wounds. Each subject receives staples as well as FS 4IU on comparable treatment sites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sheet skin grafts affixed with Fibrin Sealant (lyophilized) with 4 IU/mL Thrombin |
Timeline
- Start date
- 2002-03-01
- Completion
- 2004-01-01
- First posted
- 2005-09-13
- Last updated
- 2006-10-20
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00161759. Inclusion in this directory is not an endorsement.